KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 126 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,583 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,583 | -97.2% | 0.00% | – |
| Q1 2022 | $77,000 | +5.5% | 55,864 | -8.3% | 0.00% | – |
| Q4 2021 | $73,000 | -62.6% | 60,928 | -17.9% | 0.00% | – |
| Q3 2021 | $195,000 | -55.0% | 74,199 | -9.4% | 0.00% | – |
| Q2 2021 | $433,000 | -18.8% | 81,865 | +3.3% | 0.00% | – |
| Q1 2021 | $533,000 | -6.0% | 79,261 | -5.3% | 0.00% | – |
| Q4 2020 | $567,000 | -58.1% | 83,658 | -51.0% | 0.00% | – |
| Q3 2020 | $1,354,000 | +24.6% | 170,711 | +64.9% | 0.00% | – |
| Q2 2020 | $1,087,000 | +37.2% | 103,494 | +14.9% | 0.00% | – |
| Q1 2020 | $792,000 | -2.3% | 90,112 | -59.0% | 0.00% | – |
| Q4 2019 | $811,000 | -18.7% | 219,971 | -16.1% | 0.00% | – |
| Q3 2019 | $997,000 | -33.9% | 262,060 | +2.1% | 0.00% | – |
| Q2 2019 | $1,509,000 | -31.0% | 256,698 | -2.9% | 0.00% | – |
| Q1 2019 | $2,186,000 | +74.3% | 264,243 | +3.1% | 0.00% | – |
| Q4 2018 | $1,254,000 | -20.6% | 256,389 | +60.2% | 0.00% | – |
| Q3 2018 | $1,580,000 | -1.2% | 160,080 | +37.4% | 0.00% | – |
| Q2 2018 | $1,599,000 | -49.8% | 116,481 | -42.1% | 0.00% | -100.0% |
| Q1 2018 | $3,184,000 | -23.3% | 201,130 | -10.5% | 0.00% | 0.0% |
| Q4 2017 | $4,153,000 | +2.9% | 224,628 | +28.4% | 0.00% | 0.0% |
| Q3 2017 | $4,037,000 | – | 174,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |